company background image
002589 logo

Realcan Pharmaceutical Group XSEC:002589 Stock Report

Last Price

CN¥3.21

Market Cap

CN¥4.8b

7D

-7.5%

1Y

-1.2%

Updated

20 Dec, 2024

Data

Company Financials

Realcan Pharmaceutical Group Co., Ltd.

XSEC:002589 Stock Report

Market Cap: CN¥4.8b

002589 Stock Overview

Sells medicines, medical devices, and medical consumables to medical institution worldwide. More details

002589 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health2/6
Dividends1/6

Rewards

Became profitable this year

Risk Analysis

Debt is not well covered by operating cash flow

Earnings have declined by 11.5% per year over past 5 years


My Notes

Capture your thoughts, links and company narrative

Realcan Pharmaceutical Group Co., Ltd. Competitors

HPGC Renmintongtai Pharmaceutical

SHSE:600829

CN¥4.7b

Cowealth Medical ChinaLtd

SHSE:603122

CN¥3.1b

Cachet Pharmaceutical

SZSE:002462

CN¥4.0b

GKHT Medical Technology

SZSE:301370

CN¥5.5b

Price History & Performance

Summary of share price highs, lows and changes for Realcan Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥3.21
52 Week HighCN¥3.67
52 Week LowCN¥2.05
Beta0.51
1 Month Change-2.43%
3 Month Change36.60%
1 Year Change-1.23%
3 Year Change-15.08%
5 Year Change-58.20%
Change since IPO-77.55%

Recent News & Updates

Recent updates

Shareholder Returns

002589CN HealthcareCN Market
7D-7.5%-2.2%-1.2%
1Y-1.2%-7.7%11.8%

Return vs Industry: 002589 exceeded the CN Healthcare industry which returned -8.9% over the past year.

Return vs Market: 002589 underperformed the CN Market which returned 10.9% over the past year.

Price Volatility

Is 002589's price volatile compared to industry and market?
002589 volatility
002589 Average Weekly Movement8.2%
Healthcare Industry Average Movement8.3%
Market Average Movement8.7%
10% most volatile stocks in CN Market12.8%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 002589 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002589's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20043,239Xu Hanwww.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. The company operates in Drug and Equipment Distribution, Medical Diagnosis, Academic Service, Digital Medical, Pharmaceutical Logistics, and Traditional Chinese Medicine segments. It sells drugs and medical devices.

Realcan Pharmaceutical Group Co., Ltd. Fundamentals Summary

How do Realcan Pharmaceutical Group's earnings and revenue compare to its market cap?
002589 fundamental statistics
Market capCN¥4.80b
Earnings (TTM)CN¥39.90m
Revenue (TTM)CN¥7.99b

120.4x

P/E Ratio

0.6x

P/S Ratio

Is 002589 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002589 income statement (TTM)
RevenueCN¥7.99b
Cost of RevenueCN¥7.19b
Gross ProfitCN¥794.29m
Other ExpensesCN¥754.39m
EarningsCN¥39.90m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.027
Gross Margin9.95%
Net Profit Margin0.50%
Debt/Equity Ratio123.8%

How did 002589 perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

76%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 05:24
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Realcan Pharmaceutical Group Co., Ltd. is covered by 17 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yalei YanBohai Securities Co., Ltd.
Shuchang LiuChangjiang Securities Co. LTD.
Xu Qing LiuChasing Securities